BNP Paribas Financial Markets’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-1,153
| Closed | -$5.66K | – | 3584 |
|
|
2016
Q4 | $5.66K | Sell |
1,153
-190
| -14% | -$933 | ﹤0.01% | 3076 |
|
|
2016
Q3 | $6.66K | Buy |
1,343
+565
| +73% | +$2.8K | ﹤0.01% | 3326 |
|
|
2016
Q2 | $3.96K | Buy |
778
+589
| +312% | +$3K | ﹤0.01% | 3353 |
|
|
2016
Q1 | $1.08K | Sell |
189
-3,529
| -95% | -$20.1K | ﹤0.01% | 2497 |
|
|
2015
Q4 | $38.6K | Sell |
3,718
-444
| -11% | -$4.61K | ﹤0.01% | 2983 |
|
|
2015
Q3 | $76.9K | Buy |
4,162
+2,575
| +162% | +$47.6K | ﹤0.01% | 2558 |
|
|
2015
Q2 | $30.9K | Buy |
1,587
+1,141
| +256% | +$22.2K | ﹤0.01% | 2777 |
|
|
2015
Q1 | $7.84K | Buy |
+446
| New | +$7.84K | ﹤0.01% | 2887 |
|
|
2014
Q4 | – | Sell |
-1,249
| Closed | -$15.7K | – | 3632 |
|
|
2014
Q3 | $15.7K | Buy |
1,249
+1,240
| +13,778% | +$15.6K | ﹤0.01% | 2856 |
|
|
2014
Q2 | $141 | Sell |
9
-98
| -92% | -$1.54K | ﹤0.01% | 3250 |
|
|
2014
Q1 | $1.52K | Sell |
107
-189
| -64% | -$2.69K | ﹤0.01% | 2308 |
|
|
2013
Q4 | $4.76K | Buy |
+296
| New | +$4.76K | ﹤0.01% | 2635 |
|